Lv42
550 积分 2020-12-01 加入
Target Trial Emulation
1天前
待确认
Histopathologic Response and Oncologic Outcomes After Segmental and Subsegmental Transarterial Chemoembolization and Radioembolization for Hepatocellular Carcinoma
17天前
已完结
Improving surgical treatments for hepatocellular carcinoma
19天前
已完结
Impact of Intrahepatic Tumor Burden on Outcomes in Patients With Hepatocellular Carcinoma With Extrahepatic Metastases Treated With Atezolizumab Plus Bevacizumab
19天前
已完结
Clinical impact of extrahepatic metastatic patterns in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab
19天前
已关闭
Tumour Burden Score as a Predictor of Extrahepatic Progression After Transarterial Chemoembolization for Hepatocellular Carcinoma: An Observational Multicenter Study
1个月前
已完结
Low‐Dose Bevacizumab Maintains Efficacy With Reduced Adverse Events in Liver Cancer
1个月前
已完结
Long-term outcomes of atezolizumab–bevacizumab in unresectable hepatocellular carcinoma: A real-world study
1个月前
已完结
Global epidemiology of bacterial infections in patients with cirrhosis: a systematic review and meta-analysis
1个月前
已完结
Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial
1个月前
已完结
皖公网安备34019202002308
